Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Placebo Effect

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.

Randomized Experiments

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Use of AI within COA linguistic validation and eCOA migration processes: analysis and good practice recommendations.

Journal of patient-reported outcomes·2026

Same author

Test-retest reliability and minimal detectable change of Dutch-Flemish Patient Reported Outcomes Measurement Information System (PROMIS®) Computerized Adaptive Tests for musculoskeletal disorders.

PloS one·2025

Same author

Assessment of quality of life and wellbeing in mouse preclinical research - A scoping review.

Neuroscience applied·2025

Same author

At the core of measurement - What do you want to measure? And how do you want to measure it? A COSMIN perspective.

Journal of clinical epidemiology·2025

Same author

Assessing the measurement properties of PROMIS Computer Adaptive Tests, short forms and legacy patient reported outcome measures in patients undergoing total hip arthroplasty.

Journal of patient-reported outcomes·2024

Same author

The patient-reported outcomes measurement information systems (PROMIS®) physical function and its derivative measures in adults: a systematic review of content validity.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2022

Search research articles

Related Experiment Video

Updated: Jul 17, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study.

M P Mourits¹, M L van Kempen-Harteveld, M B García

¹Donders Institute of Ophthalmology (Orbital Unit), University Medical Centre, Utrecht, The Netherlands.

Lancet (London, England)

|May 9, 2000

Summary

Radiotherapy improved outcomes for moderately severe Graves' orbitopathy, particularly motility impairment, but did not significantly reduce proptosis or eyelid swelling. Further strabismus surgery was still required for many patients.

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Related Experiment Videos

Last Updated: Jul 17, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Area of Science:

Ophthalmology
Endocrinology
Radiation Oncology

Background:

Graves' orbitopathy is a self-limiting condition with uncertain optimal treatment for moderate severity.
Current treatment options include steroids, irradiation, or combination therapy.
The efficacy of external beam irradiation versus sham-irradiation for this condition requires investigation.

Purpose of the Study:

To evaluate the efficacy of external beam irradiation compared to sham-irradiation in patients with moderately severe Graves' orbitopathy.
To assess treatment outcomes using both qualitative and quantitative measures.

Main Methods:

A double-blind, randomized clinical trial was conducted with 60 patients.
Patients received either radiotherapy (20 Gy in ten fractions) or sham-irradiation.
Outcomes were assessed at 24 weeks using major/minor criteria, eyelid aperture, proptosis, eye movements, and clinical activity scores.

Main Results:

Qualitative outcomes were successful in 60% of irradiated patients versus 31% of sham-irradiated patients (p=0.04).
Improvements were noted in diplopia and eye elevation, but not proptosis or eyelid swelling.
Binocular single vision fields improved in the radiotherapy group, though 25% still needed strabismus surgery.

Conclusions:

Radiotherapy demonstrated efficacy in improving certain aspects of moderately severe Graves' orbitopathy.
The primary benefit of radiotherapy appears to be in treating motility impairment.
Its use should be specifically considered for motility issues in Graves' orbitopathy.